ATWCX
Price
$25.92
Change
-$0.42 (-1.59%)
Updated
Nov 13 closing price
Net Assets
981.33M
RWIEX
Price
$75.96
Change
-$1.40 (-1.81%)
Updated
Nov 13 closing price
Net Assets
144.09B
Interact to see
Advertisement

ATWCX vs RWIEX

Header iconATWCX vs RWIEX Comparison
Open Charts ATWCX vs RWIEXBanner chart's image
AB Tax-Managed Wealth Apprec Strat C
Price$25.92
Change-$0.42 (-1.59%)
VolumeN/A
Net Assets981.33M
American Funds Capital World Gr&Inc R4
Price$75.96
Change-$1.40 (-1.81%)
VolumeN/A
Net Assets144.09B
ATWCX vs RWIEX Comparison Chart in %
View a ticker or compare two or three
VS
ATWCX vs. RWIEX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATWCX is a Buy and RWIEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIEX has more cash in the bank: 144B vs. ATWCX (981M). RWIEX pays higher dividends than ATWCX: RWIEX (1.35) vs ATWCX (0.00). ATWCX was incepted earlier than RWIEX: ATWCX (22 years) vs RWIEX (23 years). ATWCX (2.06) is less costly to investors than RWIEX (0.76). RWIEX is a more actively managed with annual turnover of: 27.00 vs. ATWCX (10.00). RWIEX has a lower initial minimum investment than ATWCX: RWIEX (250) vs ATWCX (2500). ATWCX (13.53) and RWIEX (13.46) have marching annual gain over last year. ATWCX return over 5 years is better than : 50.17 vs. RWIEX (45.13).
ATWCXRWIEXATWCX / RWIEX
Total Expense Ratio1.740.76229%
Annual Report Gross Expense Ratio2.060.76271%
Fund Existence22 years23 years-
Gain YTD17.71121.18384%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets981M144B1%
Annual Yield % from dividends0.001.35-
Returns for 1 year13.5313.46101%
Returns for 3 years52.9254.1998%
Returns for 5 years50.1745.13111%
Returns for 10 years71.3880.5589%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRCE3.100.07
+2.31%
Grace Therapeutics Inc
GRFS8.700.01
+0.12%
Grifols SA
ALFUU11.00N/A
N/A
Centurion Acquisition Corp
LKFN58.25-0.08
-0.14%
Lakeland Financial Corp
XFOR3.73-0.14
-3.62%
X4 Pharmaceuticals Inc